COSYNE
Live / Registered — Registered (as of 14 Nov 2023)
What this means for you
Registered since 14 Nov 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97976494
- Registration number
- 7220288
- Mark type
- Stylized text
- Filed
- 20 May 2022
- Published for opposition
- 09 May 2023
- Registered
- 14 Nov 2023
- Attorney of record
- NIGAMNARAYAN ACHARYA
Goods and services
- Class 042 — Scientific and technological services: Drug discovery services; Scientific research for medical purposes in the fields of neuroscience, genetics and computational analysis, and cancer; research and development of pharmaceuticals for the treatment of neurological diseases and cancer; medical and scientific research in the field of pharmaceuticals; pharmaceutical products development; medical research; pharmaceutical testing, pre-clinical research, clinical research, and clinical trials for pharmaceutical product development
Owner
- CoSyne Therapeutics Limited, London, GB
- CoSyne Therapeutics Limited, London, GB
- CoSyne Therapeutics Limited, London, GB
Prosecution history
- 14 Nov 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 14 Nov 2023 — REGISTERED-PRINCIPAL REGISTER
- 10 Oct 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 09 Oct 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 19 Sept 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 21 Aug 2023 — USE AMENDMENT FILED
- 19 Sept 2023 — DIVISIONAL PROCESSING COMPLETE
- 21 Aug 2023 — DIVISIONAL REQUEST RECEIVED
- 26 Aug 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 21 Aug 2023 — TEAS REQUEST TO DIVIDE RECEIVED
- 21 Aug 2023 — TEAS STATEMENT OF USE RECEIVED
- 04 Jul 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 09 May 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 May 2023 — PUBLISHED FOR OPPOSITION
- 19 Apr 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED